Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1.23	0.09	2.47	6.66	11.06
Short-Term Investments	-	-	-	-	5.06
Cash & Short-Term Investments	1.23	0.09	2.47	6.66	16.12
Cash Growth	1199.83%	-96.17%	-63.00%	-58.67%	52.98%
Other Receivables	1.67	1.17	0.42	1.39	1.69
Receivables	1.67	1.17	0.42	1.39	1.69
Prepaid Expenses	0.11	0.19	0.23	0.18	0.45
Total Current Assets	3.01	1.46	3.12	8.24	18.26
Property, Plant & Equipment	0.02	0.03	0.01	0.04	0.05
Total Assets	3.03	1.49	3.13	8.28	18.32
Accounts Payable	4.02	4.11	2.75	6.38	4.45
Accrued Expenses	0.09	0.08	0.08	0.07	0.08
Current Portion of Long-Term Debt	11.56	7.31	0.11	0.1	0.09
Current Income Taxes Payable	0.03	0.05	0.04	-	-
Total Current Liabilities	15.69	11.54	2.98	6.67	4.62
Long-Term Debt	0.74	0.88	7.55	4.88	0.95
Total Liabilities	16.43	12.42	10.53	11.55	5.56
Common Stock	42.32	42.32	42.32	39.65	34.96
Additional Paid-In Capital	14.82	12.87	6.41	5.01	2.55
Retained Earnings	-71.72	-69.09	-65.31	-56.07	-30.95
Comprehensive Income & Other	1.18	2.98	9.18	8.13	6.19
Shareholders' Equity	-13.4	-10.92	-7.4	-3.27	12.75
Total Liabilities & Equity	3.03	1.49	3.13	8.28	18.32
Total Debt	12.29	8.18	7.67	4.98	1.03
Net Cash (Debt)	-11.07	-8.09	-5.2	1.69	15.09
Net Cash Growth	-	-	-	-88.83%	58.28%
Net Cash Per Share	-0.09	-0.07	-0.05	0.03	0.26
Filing Date Shares Outstanding	121.27	121.27	121.27	121.27	62.83
Total Common Shares Outstanding	121.27	121.27	121.27	71.27	62.78
Working Capital	-12.68	-10.08	0.14	1.57	13.65
Book Value Per Share	-0.11	-0.09	-0.06	-0.05	0.20
Tangible Book Value	-13.4	-10.92	-7.4	-3.27	12.75
Tangible Book Value Per Share	-0.11	-0.09	-0.06	-0.05	0.20
Machinery	-	-	0.06	0.13	0.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.